Facebook
Britain's News Portal
Around The Clock
BREAKING
Loading latest headlines…

Bacterial toxin a 'leading suspect' in rise of early-onset bowel cancer

Scientists suggest a bacterial toxin, colibactin, produced by E coli, is a potential driver in the increase of bowel cancer cases among those under 50.

  • Cases of early-onset bowel cancer have doubled in many countries over the past two decades.
  • Colibactin, a toxin from some E coli variants, was identified last year as a potential driver of early-onset colorectal cancer.
  • Hallmark mutations caused by colibactin were three times more common in tumours from people under 40 than in those over 70.

Exposure to a bacterial toxin in early life has emerged as a leading suspect in the rise of bowel cancer among people under 50, according to scientists speaking to a Commons committee. Cases of early-onset bowel cancer have doubled in many countries over the past two decades.

While rising obesity and a decline in physical activity are known contributors, researchers believe other factors must also be involved. Dr Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, told the Commons science and technology committee that known risk factors explain only about half of diagnosed colorectal cancer cases.

Last year, scientists identified colibactin, a toxin produced by some variants of E coli bacteria in the gut, as a potential driver of early-onset colorectal cancer. Mutations caused by this toxin were found to be three times more common in tumours from individuals under 40 compared to those over 70.

Professor Elio Riboli, a cancer epidemiologist at Imperial College London, noted that colibactin is primarily found in people born after 1960, suggesting a possible mutation in E coli bacteria. Professor Helen Coleman, a cancer epidemiologist at Queen's University Belfast, described colibactin as "the first new clue that we've had in quite some time," though its role is still under investigation.

Why this matters: The potential identification of a new driver for early-onset bowel cancer could lead to new avenues for understanding and potentially preventing the disease, which has seen a significant rise in younger populations.

Related Articles

Get the news that matters.

Join thousands of readers getting the best of British news straight to their inbox.